撤回：替莫唑胺联合放疗治疗恶性胶质瘤的疗效与安全性。
Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma.
作者信息
Engineering Journal Of Healthcare
出版信息
J Healthc Eng. 2023 Jan 19;2023:9820907. doi: 10.1155/2023/9820907. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/3477918.].
摘要
[本文撤回文章DOI: 10.1155/2022/3477918。]
相似文献
1
Retracted: Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma.撤回：替莫唑胺联合放疗治疗恶性胶质瘤的疗效与安全性。
J Healthc Eng. 2023 Jan 19;2023:9820907. doi: 10.1155/2023/9820907. eCollection 2023.
2
Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma.撤稿：替莫唑胺单药与联合阿霉素治疗胶质瘤的临床效果比较
J Healthc Eng. 2023 Jul 12;2023:9837208. doi: 10.1155/2023/9837208. eCollection 2023.
3
Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.撤回：TTC7B是胶质瘤中一种与预后相关的新型生物标志物，与免疫浸润及对替莫唑胺诱导的氧化应激反应相关。
Oxid Med Cell Longev. 2023 Sep 27;2023:9787264. doi: 10.1155/2023/9787264. eCollection 2023.
4
Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma.替莫唑胺联合放疗治疗恶性脑胶质瘤的疗效及安全性。
J Healthc Eng. 2022 Feb 15;2022:3477918. doi: 10.1155/2022/3477918. eCollection 2022.
5
Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma.术后替莫唑胺同步放化疗治疗恶性胶质瘤的疗效与毒性
Strahlenther Onkol. 2005 Mar;181(3):157-63. doi: 10.1007/s00066-005-1314-x.
6
[Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].三维适形放疗联合替莫唑胺治疗胶质瘤的疗效与安全性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1106-10. doi: 10.3969/j.issn.1672-7347.2011.11.013.
7
[Safety and efficacy of three-dimensional conformal radiotherapy combined with temozolomide in treatment of diffuse brainstem gliomas].三维适形放疗联合替莫唑胺治疗弥漫性脑干胶质瘤的安全性与疗效
Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):707-9.
8
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model.VEGFR抑制剂ZD6474联合放疗和替莫唑胺在原位胶质瘤模型中的作用
J Neurooncol. 2008 May;88(1):1-9. doi: 10.1007/s11060-008-9527-3. Epub 2008 Jan 29.
9
Retracted: The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis.撤回：放射治疗和化学疗法联合过继性免疫疗法治疗非小细胞肺癌的临床疗效与安全性分析：系统评价与Meta分析
Appl Bionics Biomech. 2023 Oct 4;2023:9873947. doi: 10.1155/2023/9873947. eCollection 2023.
10
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.聚乙二醇丙交酯-乙交酯共聚物20，含3.85%卡莫司汀缓释晶片用于恶性胶质瘤：在标准辅助替莫唑胺时代的作用证据
Core Evid. 2012;7:115-30. doi: 10.2147/CE.S23244. Epub 2012 Oct 26.
本文引用的文献
1
Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma.替莫唑胺联合放疗治疗恶性脑胶质瘤的疗效及安全性。
J Healthc Eng. 2022 Feb 15;2022:3477918. doi: 10.1155/2022/3477918. eCollection 2022.
Zotero 插件